FindTrial
Sign In

Role of imaging in the diagnosis of extrapulmonary manifestations of COVID 19

Role of imaging in the diagnosis of extrapulmonary manifestations of COVID 19

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/12/030048
Enrollment
50
Registered
2020-12-28
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere

Interventions

Control Intervention1: NIL: NIL

Sponsors

Lokesh M
Lead Sponsor
Rajeswaran
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: (i) Positive nasopharyngeal or lower respiratory tract reverse transcriptase-polymerase chain reaction assays; (ii) Neurologic/ abdominal/ vascular manifestations (iii) Abnormal CT/ MRI brain, USG/CT abdomen, USG doppler / CT Angiogram / venogram.

Exclusion criteria

Exclusion criteria: (i) Negative test for COVID (ii) Chronic lesions not related to COVID (iii) Ischemic lesions/ infarcts not attributable to COVID (iv) Where follow up could not be done

Design outcomes

Primary

MeasureTime frame
Clinical recovery of the patientTimepoint: At baseline at 4 weeks—

Secondary

MeasureTime frame
Complications during hospital stay and immediately after dischargeTimepoint: At baseline at 4 weeks—

Countries

India

Contacts

Public ContactLokesh M

Sri Ramachandra Institute of higher education and research

rrajeswaran2000@gmail.com9841311552

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026